The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Anthem Biosciences IPO
Anthem Biosciences
MainboardListed

Anthem Biosciences IPO

Bidding 14-16 Jul 2025, price band ₹540–570, lot 26 shares.

OverviewGMPAllotment

Grey Market Premium Trend

GMP last updated: 21 Jul 2025, 10:00 AM IST

₹179
Final GMP
₹749
GMP-Implied Listing Price
31.4%
GMP-Implied Gain
₹540 - ₹570
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
20 Jul₹179₹74931.40%
19 Jul₹177₹74731.05%
18 Jul₹163₹73328.60%
17 Jul₹132₹70223.16%
16 Jul₹143₹71325.09%
15 Jul₹144₹71425.26%
14 Jul₹156₹72627.37%
13 Jul₹116₹68620.35%
12 Jul₹100₹67017.54%
11 Jul₹99₹66917.37%
10 Jul₹97₹66717.02%
9 Jul₹107₹67718.77%
8 Jul₹103₹67318.07%
7 Jul₹66₹63611.58%
6 Jul₹0₹5700.00%
5 Jul₹0₹5700.00%
4 Jul₹0₹5700.00%
3 Jul₹0₹5700.00%
2 Jul₹0₹5700.00%
1 Jul₹0₹5700.00%
30 Jun₹0₹5700.00%
29 Jun₹0₹5700.00%

IPO timeline

  1. Issue open date
    14 Jul 2025
  2. Issue close date
    16 Jul 2025
  3. UPI mandate deadline
    16 Jul 2025
  4. Allotment finalization
    17 Jul 2025
  5. Refund initiation
    18 Jul 2025
  6. Share credit
    18 Jul 2025
  7. Listing date
    21 Jul 2025
  8. Mandate end date
    31 Jul 2025
  9. Lock-in end date for anchor investors (50%)
    16 Aug 2025
  10. Lock-in end date for anchor investors (remaining)
    15 Oct 2025

Anthem Biosciences IPO Allotment Status

Allotment date:17 Jul 2025
Registrar:Kfin Technologies Limited
  1. Open the registrar's allotment page from the link below.
  2. Select Anthem Biosciences from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on Kfin Technologies(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:18 Jul 2025
Shares credited to demat:18 Jul 2025
Listing:21 Jul 2025
💸

IPO Subscription Status

CategoryTimesEst. Allotment Chances*
HNIs (Total)44.69🔥2.2%
HNIs 10+51.66🔥1.9%
HNIs 2+30.76🔥3.3%
QIBs192.8🔥-
Retail5.89🔥17.0%
Employees6.89🔥14.5%

*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.

Last updated: 16 July'25 10:14PM

Quick Stats

Issue Size:3395cr
Lot Size:26 shares
Min Investment:₹14,820
P/E Ratio:70.62

About the Company

Anthem Biosciences, established in 2006, is an innovation-driven Contract Research, Development, and Manufacturing Organisation (CRDMO) that offers integrated services in drug discovery, development, and manufacturing. The company specialises in fermentation-based APIs, including probiotics, enzymes, peptides, and biosimilars, catering to both biotech startups and large pharma worldwide. With 196 active projects, including 170 discovery projects, Anthem’s R&D spans RNAi, ADCs, and peptides. The company’s manufacturing facilities, including one under construction, support a broad portfolio of custom synthesis and fermentation capabilities. Known for green chemistry and cutting-edge technologies, Anthem is a leader in delivering sustainable, high-quality solutions across regulated markets.

Strengths

  • Comprehensive services across the drug life cycle for small molecules and biologics
  • Focus on advanced solutions across modalities and manufacturing practices
  • Specialised model for small pharmaceutical and biotech companies
  • Established customer base with ongoing relationships
  • Experienced leadership and skilled scientific team

Risks

  • Failure to develop new or improve existing technologies.
  • Delays in obtaining regulatory approvals.
  • Under-utilisation of manufacturing capacity and demand forecasting issues.
  • Pricing pressures affecting product prices and profitability.
  • Risks from data security breaches and failure to safeguard sensitive information.
  • Seasonality affecting business performance and cash flow.

Anthem Biosciences IPO – Frequently Asked Questions

  • The price band for the Anthem Biosciences IPO is set at ₹540 to ₹570 per share.
  • The Anthem Biosciences IPO opens on July 14, 2025 and closes on July 16, 2025.
  • The tentative listing date for the Anthem Biosciences IPO is July 21, 2025.
  • The last recorded Grey Market Premium (GMP) for the Anthem Biosciences IPO before listing was ₹179 (31.4%). GMP is unofficial and is not a guarantee of the listing price.
  • The Anthem Biosciences IPO allotment date is July 17, 2025. Once it is finalised, check your status with your PAN or application number on the website of the registrar, Kfin Technologies Limited. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Anthem Biosciences IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Anthem Biosciences, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Anthem Biosciences IPO is 26 shares. Investors must apply for at least one lot (i.e., 26 shares), which costs ₹14,820 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent mainboard listings

  • Bombay Coated & Special SteelsListed 5 Nov 2026
    +10.98%
  • M.K.Sons Fine JewelsListed 4 Nov 2026
    +5.56%
  • BLS PolymersListed 3 Nov 2026
    +65.33%
  • SFC Environmental TechnologiesListed 3 Nov 2026
    +7.61%
  • EAAA India AlternativesListed 2 Nov 2026
    +0.63%
  • Jio PlatformsListed 28 Oct 2026
    +21.36%

All IPOs that opened in July 2025